BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33455115)

  • 1. Identification of key pathways and biomarkers in anaplastic thyroid cancer using an integrated analysis.
    Zhou J; Dong S; Shi C
    J BUON; 2020; 25(6):2690-2699. PubMed ID: 33455115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Hub Genes in Anaplastic Thyroid Carcinoma: Evidence From Bioinformatics Analysis.
    Li L; Zhu M; Huang H; Wu J; Meng D
    Technol Cancer Res Treat; 2020; 19():1533033820962135. PubMed ID: 33025856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key genes involved in cell cycle arrest and DNA damage repair identified in anaplastic thyroid carcinoma using integrated bioinformatics analysis.
    Zhang Z; Zou Z; Dai H; Ye R; Di X; Li R; Ha Y; Sun Y; Gan S
    Transl Cancer Res; 2020 Jul; 9(7):4188-4203. PubMed ID: 35117787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Bioinformatics Analysis of Master Regulators in Anaplastic Thyroid Carcinoma.
    Pan Z; Li L; Fang Q; Qian Y; Zhang Y; Zhu J; Ge M; Huang P
    Biomed Res Int; 2019; 2019():9734576. PubMed ID: 31183379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key candidate genes and pathways in anaplastic thyroid cancer by bioinformatics analysis.
    Ding YG; Ren YL; Xu YS; Wei CS; Zhang YB; Zhang SK; Guo CA
    Am J Otolaryngol; 2020; 41(3):102434. PubMed ID: 32093976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMEM158 May Serve as a Diagnostic Biomarker for Anaplastic Thyroid Carcinoma: An Integrated Bioinformatic Analysis.
    Li HN; Du YY; Xu T; Zhang R; Wang G; Lv ZT; Li XR
    Curr Med Sci; 2020 Dec; 40(6):1137-1147. PubMed ID: 33428142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of Novel Genes in Anaplastic Thyroid Carcinoma via Bioinformatics Analysis.
    Wang S; Wu J; Guo C; Shang H; Yao J; Liao L; Dong J
    Cancer Manag Res; 2020; 12():9787-9799. PubMed ID: 33116838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of key pathways and drug repurposing for anaplastic thyroid carcinoma by integrated bioinformatics analysis].
    Pan Z; Fang Q; Zhang Y; Li L; Huang P
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(2):187-193. PubMed ID: 30226315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of transcriptome data revealed MMP3 and MMP13 as critical genes in anaplastic thyroid cancer progression.
    Ma Y; Cang S; Li G; Su Y; Zhang H; Wang L; Yang J; Shi X; Qin G; Yuan H
    J Cell Physiol; 2019 Dec; 234(12):22260-22271. PubMed ID: 31081124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differences of regulatory networks between papillary and anaplastic thyroid carcinoma: an integrative transcriptomics study.
    Pan Z; Li L; Qian Y; Ge X; Hu X; Zhang Y; Ge M; Huang P
    Cancer Biol Ther; 2020 Sep; 21(9):853-862. PubMed ID: 32887540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analysis of key genes and latent pathway interactions based on the anaplastic thyroid carcinoma gene expression profile.
    Huang Y; Tao Y; Li X; Chang S; Jiang B; Li F; Wang ZM
    Oncol Lett; 2017 Jan; 13(1):167-176. PubMed ID: 28428828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes and pathways identified in thyroid carcinoma based on bioinformatics analysis.
    Yu JW; Mai W; Cui YL; Kong LY
    Neoplasma; 2016; 63(4):559-68. PubMed ID: 27268919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
    Gu P; Yang D; Zhu J; Zhang M; He X
    Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of the molecular mechanisms of anaplastic thyroid carcinoma by integrated miRNA and mRNA analysis.
    Liu G; Wu K; Sheng Y
    Oncol Rep; 2016 Nov; 36(5):3005-3013. PubMed ID: 27599582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel characteristic biomarkers and immune infiltration profile for the anaplastic thyroid cancer via machine learning algorithms.
    Li C; Dong X; Yuan Q; Xu G; Di Z; Yang Y; Hou J; Zheng L; Chen W; Wu G
    J Endocrinol Invest; 2023 Aug; 46(8):1633-1650. PubMed ID: 36725810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of Key Genes in Human Anaplastic Thyroid Cancer via the Weighing Gene Coexpression Network.
    Gong Y; Xu F; Deng L; Peng L
    Biomed Res Int; 2022; 2022():2244228. PubMed ID: 35782055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Bioinformatics Analysis of Hub Genes and Pathways in Anaplastic Thyroid Carcinomas.
    Gao X; Wang J; Zhang S
    Int J Endocrinol; 2019; 2019():9651380. PubMed ID: 30774662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.